For the quarter ending 2025-09-30, PTHS has $126,433,000 in assets. $68,180,000 in debts.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Deferred offering costs | - | 710,937 | ||
| Due from chromocell corporation | - | 40,400 | ||
| Cash and cash equivalents | 14,203,000 | 59,172 | ||
| Restricted cash, current | 50,000 | - | ||
| Accounts receivable, net | 7,988,000 | - | ||
| Inventory, net | 24,096,000 | - | ||
| Prepaid expenses and other current assets | 3,424,000 | 12,341 | ||
| Total current assets | 49,761,000 | 822,850 | ||
| Property and equipment, net | 10,174,000 | - | ||
| Operating lease right-of-use assets, net | 3,352,000 | - | ||
| Intangible assets, net | 32,521,000 | - | ||
| Goodwill | 30,625,000 | - | ||
| Total assets | 126,433,000 | 822,850 | ||
| Accounts payable | 5,666,000 | - | ||
| Loan payable, net of debt discount | - | 2,172,819 | ||
| Loan payable - related party, net of debt discount | - | 131,868 | ||
| Accrued expenses | 11,890,000 | 23,636 | ||
| Operating lease liabilities, current portion | 631,000 | - | ||
| Deferred revenue, current portion | 1,019,000 | - | ||
| Accounts payable and accrued expenses | - | 4,988,822 | ||
| Other liabilities | 5,562,000 | - | ||
| Total current liabilities | 24,768,000 | 7,317,145 | ||
| Operating lease liabilities, net of current portion | 2,849,000 | - | ||
| Deferred revenue, net of current portion | 1,522,000 | - | ||
| Deferred income tax liability | 12,866,000 | - | ||
| Preferred stock, value, issued-Series CPreferred Stock | - | 0 | ||
| Preferred stock, value, issued-Series APreferred Stock | - | 0 | ||
| Other long-term liabilities | 26,175,000 | - | ||
| Common stock, 0.0001par value,200,000,000shares authorized,673,320 and610,389shares issued and outstanding as of june 30, 2025 and december 31, 2024, respectively | - | 67 | ||
| Total liabilities | 68,180,000 | 7,317,145 | ||
| Additional paid in capital | 101,383,000 | 20,397,175 | ||
| Accumulated deficit | -43,130,000 | -26,891,537 | ||
| Total stockholders equity (deficit) | 58,253,000 | -6,494,295 | ||
| Total liabilities and stockholders equity (deficit) | 126,433,000 | 822,850 | ||
Pelthos Therapeutics Inc. (PTHS)
Pelthos Therapeutics Inc. (PTHS)